235 related articles for article (PubMed ID: 26105201)
1. A comparison of resource utilization following chemotherapy for acute myeloid leukemia in children discharged versus children that remain hospitalized during neutropenia.
Getz KD; Miller TP; Seif AE; Li Y; Huang YS; Bagatell R; Fisher BT; Aplenc R
Cancer Med; 2015 Sep; 4(9):1356-64. PubMed ID: 26105201
[TBL] [Abstract][Full Text] [Related]
2. Resource Utilization and Safety of Outpatient Management Following Intensive Induction or Salvage Chemotherapy for Acute Myeloid Leukemia or Myelodysplastic Syndrome: A Nonrandomized Clinical Comparative Analysis.
Vaughn JE; Othus M; Powell MA; Gardner KM; Rizzuto DL; Hendrie PC; Becker PS; Pottinger PS; Estey EH; Walter RB
JAMA Oncol; 2015 Nov; 1(8):1120-7. PubMed ID: 26355382
[TBL] [Abstract][Full Text] [Related]
3. Medical Outcomes, Quality of Life, and Family Perceptions for Outpatient vs Inpatient Neutropenia Management After Chemotherapy for Pediatric Acute Myeloid Leukemia.
Getz KD; Szymczak JE; Li Y; Madding R; Huang YV; Aftandilian C; Arnold SD; Bona KO; Caywood E; Collier AB; Gramatges MM; Henry M; Lotterman C; Maloney K; Mian A; Mody R; Morgan E; Raetz EA; Rubnitz J; Verma A; Winick N; Wilkes JJ; Yu JC; Fisher BT; Aplenc R
JAMA Netw Open; 2021 Oct; 4(10):e2128385. PubMed ID: 34709389
[TBL] [Abstract][Full Text] [Related]
4. A comparison of discharge strategies after chemotherapy completion in pediatric patients with acute myeloid leukemia: a report from the Children's Oncology Group.
Miller TP; Getz KD; Kavcic M; Li Y; Huang YS; Sung L; Alonzo TA; Gerbing R; Daves M; Horton TM; Pulsipher MA; Pollard J; Bagatell R; Seif AE; Fisher BT; Gamis AS; Aplenc R
Leuk Lymphoma; 2016 Jul; 57(7):1567-74. PubMed ID: 26727639
[TBL] [Abstract][Full Text] [Related]
5. Selective discharge of patients with acute myeloid leukemia during chemotherapy-induced neutropenia.
Gillis S; Dann EJ; Rund D
Am J Hematol; 1996 Jan; 51(1):26-31. PubMed ID: 8571934
[TBL] [Abstract][Full Text] [Related]
6. Early discharge as a mediator of greater ICU-level care requirements in patients not enrolled on the AAML0531 clinical trial: a Children's Oncology Group report.
Getz KD; Miller TP; Seif AE; Li Y; Huang YS; Alonzo T; Gerbing R; Sung L; Hall M; Bagatell R; Gamis A; Fisher BT; Aplenc R
Cancer Med; 2016 Sep; 5(9):2412-6. PubMed ID: 27474232
[TBL] [Abstract][Full Text] [Related]
7. Outpatient supportive care following chemotherapy for acute myeloblastic leukemia.
Allan DS; Buckstein R; Imrie KR
Leuk Lymphoma; 2001 Jul; 42(3):339-46. PubMed ID: 11699398
[TBL] [Abstract][Full Text] [Related]
8. Induction mortality and resource utilization in children treated for acute myeloid leukemia at free-standing pediatric hospitals in the United States.
Kavcic M; Fisher BT; Li Y; Seif AE; Torp K; Walker DM; Huang YS; Lee GE; Tasian SK; Vujkovic M; Bagatell R; Aplenc R
Cancer; 2013 May; 119(10):1916-23. PubMed ID: 23436301
[TBL] [Abstract][Full Text] [Related]
9. Out-patient management of acute myeloid leukemia after consolidation chemotherapy. Role of a hematologic emergency unit.
Girmenia C; Alimena G; Latagliata R; Morano SG; Celesti F; Coppola L; Spadea A; Tosti S; Mecarocci S; D'Elia GM; Tafuri A; Cimino G; Mandelli F
Haematologica; 1999 Sep; 84(9):814-9. PubMed ID: 10477455
[TBL] [Abstract][Full Text] [Related]
10. Comparison of in-patient costs for children treated on the AAML0531 clinical trial: A report from the Children's Oncology Group.
Getz KD; Li Y; Alonzo TA; Hall M; Gerbing RB; Sung L; Huang YS; Arnold S; Seif AE; Miller TP; Bagatell R; Fisher BT; Adamson PC; Gamis A; Keren R; Aplenc R
Pediatr Blood Cancer; 2015 Oct; 62(10):1775-81. PubMed ID: 25946708
[TBL] [Abstract][Full Text] [Related]
11. Outpatient supportive care for pediatric acute myeloid leukemia: a single institution's experience.
Potashner R; Weinblatt ME; Glasser CL
Pediatr Hematol Oncol; 2021 Nov; 38(8):722-730. PubMed ID: 33792501
[TBL] [Abstract][Full Text] [Related]
12. Outpatient consolidation chemotherapy in pediatric acute myeloid leukemia: a retrospective analysis.
Bakhshi S; Singh P; Swaroop C
Hematology; 2009 Oct; 14(5):255-60. PubMed ID: 19843379
[TBL] [Abstract][Full Text] [Related]
13. Association between prolonged neutropenia and reduced relapse risk in pediatric AML: A report from the children's oncology group.
Sung L; Aplenc R; Alonzo TA; Gerbing RB; Wang YC; Meshinchi S; Gamis AS
Int J Cancer; 2016 Nov; 139(9):1930-5. PubMed ID: 27312107
[TBL] [Abstract][Full Text] [Related]
14. Economic comparison of home-care-based versus hospital-based treatment of chemotherapy-induced febrile neutropenia in children.
Raisch DW; Holdsworth MT; Winter SS; Hutter JJ; Graham ML
Value Health; 2003; 6(2):158-66. PubMed ID: 12641866
[TBL] [Abstract][Full Text] [Related]
15. Invasive fungal disease in pediatric acute leukemia patients with fever and neutropenia during induction chemotherapy: a multivariate analysis of risk factors.
Wiley JM; Smith N; Leventhal BG; Graham ML; Strauss LC; Hurwitz CA; Modlin J; Mellits D; Baumgardner R; Corden BJ
J Clin Oncol; 1990 Feb; 8(2):280-6. PubMed ID: 2299371
[TBL] [Abstract][Full Text] [Related]
16. The role of acuity of illness at presentation in early mortality in black children with acute myeloid leukemia.
Winestone LE; Getz KD; Miller TP; Wilkes JJ; Sack L; Li Y; Huang YS; Seif AE; Bagatell R; Fisher BT; Epstein AJ; Aplenc R
Am J Hematol; 2017 Feb; 92(2):141-148. PubMed ID: 27862214
[TBL] [Abstract][Full Text] [Related]
17. Comparison of administrative/billing data to expected protocol-mandated chemotherapy exposure in children with acute myeloid leukemia: A report from the Children's Oncology Group.
Miller TP; Troxel AB; Li Y; Huang YS; Alonzo TA; Gerbing RB; Hall M; Torp K; Fisher BT; Bagatell R; Seif AE; Sung L; Gamis A; Rubin D; Luger S; Aplenc R
Pediatr Blood Cancer; 2015 Jul; 62(7):1184-9. PubMed ID: 25760019
[TBL] [Abstract][Full Text] [Related]
18. Early hospital discharge followed by outpatient management versus continued hospitalization of children with cancer, fever, and neutropenia at low risk for invasive bacterial infection.
Santolaya ME; Alvarez AM; Avilés CL; Becker A; Cofré J; Cumsille MA; O'Ryan ML; Payá E; Salgado C; Silva P; Tordecilla J; Varas M; Villarroel M; Viviani T; Zubieta M
J Clin Oncol; 2004 Sep; 22(18):3784-9. PubMed ID: 15365075
[TBL] [Abstract][Full Text] [Related]
19. Outpatient management of acute myeloid leukemia after intensive consolidation chemotherapy is feasible and reduces hospital treatment costs.
Eisele L; Günther F; Ebeling P; Nabring J; Dührsen U; Dürig J
Onkologie; 2010; 33(12):658-64. PubMed ID: 21124036
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
